| scholarly article | Q13442814 |
| P356 | DOI | 10.1155/2011/281651 |
| P8608 | Fatcat ID | release_l3idd46gsnfl7fmvn4xlivjuxe |
| P932 | PMC publication ID | 3134191 |
| P698 | PubMed publication ID | 21765632 |
| P5875 | ResearchGate publication ID | 51498864 |
| P2093 | author name string | Han Li | |
| Zhang Yan | |||
| Wang Ning | |||
| Ma Fang | |||
| Guo Xiao-Juan | |||
| Jiang Jin-Hua | |||
| Wang Qing-Duan | |||
| Zang Cai-Hong | |||
| P2860 | cites work | Binocular diplopia and ptosis due to snakebite (Agkistrodon blomhoffi "mamushi")--a case report | Q28276656 |
| Effect of honey and eugenol on Ehrlich ascites and solid carcinoma. | Q33758091 | ||
| In vitro and in vivo multidrug resistance reversal activity by a Betti-base derivative of tylosin | Q34005841 | ||
| CD56 is a sensitive and diagnostically useful immunohistochemical marker of ovarian sex cord-stromal tumors | Q34639727 | ||
| Multidrug resistance: retrospect and prospects in anti-cancer drug treatment. | Q36536479 | ||
| Functional subsets of mouse natural killer cells | Q36652157 | ||
| The effects of biscoclaurine alkaloid cepharanthine on mammalian cells: implications for cancer, shock, and inflammatory diseases | Q36699612 | ||
| Systemic treatment of hepatocellular carcinoma: dawn of a new era? | Q37734303 | ||
| Nanomedicinal strategies to treat multidrug-resistant tumors: current progress | Q37763152 | ||
| [The effects of Cepharanthin on the recovery of hematopoietic stem cells after X-ray irradiation] | Q68183038 | ||
| Direct antitumor effect of cepharanthin and combined effect with adriamycin against Ehrlich ascites tumor in mice | Q72199994 | ||
| ABCB1 (P-glycoprotein) but not ABCC1 (MRP1) is downregulated in peripheral blood mononuclear cells of spontaneously hypertensive rats | Q80143511 | ||
| Phase I/II trial of a P-glycoprotein inhibitor, Zosuquidar.3HCl trihydrochloride (LY335979), given orally in combination with the CHOP regimen in patients with non-Hodgkin's lymphoma | Q80206172 | ||
| Independent regulation of ABCB1 and ABCC activities in thymocytes and bone marrow mononuclear cells during aging | Q80627829 | ||
| Future perspectives in hepatocellular carcinoma | Q37765050 | ||
| Green tea catechins augment the antitumor activity of doxorubicin in an in vivo mouse model for chemoresistant liver cancer | Q39698140 | ||
| Decreased expression of KAI1/CD82 metastasis suppressor gene is associated with loss of heterozygosity in melanoma cell lines. | Q39905287 | ||
| P-Glycoprotein inhibitory activity of lipophilic constituents of Echinacea pallida roots in a human proximal tubular cell line | Q39990056 | ||
| Reversal of P-glycoprotein-mediated paclitaxel resistance by new synthetic isoprenoids in human bladder cancer cell line | Q40700402 | ||
| Modulation by LY335979 of P-glycoprotein function in multidrug-resistant cell lines and human natural killer cells | Q40710163 | ||
| P-glycoprotein expression on normal and abnormally expanded natural killer cells and inhibition of P-glycoprotein function by cyclosporin A and its analogue, PSC833. | Q40981698 | ||
| Combined use of tamoxifen, cyclosporin A, and verapamil for modulating multidrug resistance in human hepatocellular carcinoma cell lines | Q41570508 | ||
| Rhodamine 123 binds to multiple sites in the multidrug resistance protein (MRP1). | Q41920705 | ||
| In vitro cytotoxicity of CD8+ T cells in multi-drug-resistant tuberculosis. A preliminary report | Q42448865 | ||
| Absence of both cytochrome P450 3A and P-glycoprotein dramatically increases docetaxel oral bioavailability and risk of intestinal toxicity | Q43240239 | ||
| Modulation of doxorubicin sensitivity by cyclosporine A in hepatocellular carcinoma cells and their doxorubicin-resistant sublines | Q43608675 | ||
| Phase 3 study of the multidrug resistance modulator PSC-833 in previously untreated patients 60 years of age and older with acute myeloid leukemia: Cancer and Leukemia Group B Study 9720. | Q44083625 | ||
| Inhibitory effect of fruit extracts on P-glycoprotein-related efflux carriers: an in-vitro screening. | Q44160439 | ||
| Toxicologic and pharmacokinetic study of low doses of verapamil combined with doxorubicin. | Q44199622 | ||
| A phase I study of the P-glycoprotein antagonist tariquidar in combination with vinorelbine | Q44947330 | ||
| A phase I/II study of infusional vinblastine with the P-glycoprotein antagonist valspodar (PSC 833) in renal cell carcinoma | Q44989607 | ||
| Myelotoxicity of preoperative chemoradiotherapy is a significant determinant of poor prognosis in patients with T4 esophageal cancer | Q46146861 | ||
| P-glycoprotein function in peripheral T lymphocyte subsets of myasthenia gravis patients: clinical implications and influence of glucocorticoid administration | Q46186904 | ||
| Reversal of multidrug resistance in drug-resistant cell line EAC/ADR by cepharanthine hydrochloride and its mechanism | Q46543031 | ||
| In vivo and in vitro modulation of MDR molecules in murine thymocytes | Q46884513 | ||
| The in vivo effect of the administration of resistance-modulating agents on rhodamine 123 distribution in mice thymus and lymph nodes. | Q48181735 | ||
| P275 | copyright license | Creative Commons Attribution 3.0 Unported | Q14947546 |
| P6216 | copyright status | copyrighted | Q50423863 |
| P304 | page(s) | 281651 | |
| P577 | publication date | 2011-06-30 | |
| P1433 | published in | Journal of Biomedicine and Biotechnology | Q15752146 |
| P1476 | title | Using rhodamine 123 accumulation in CD8 cells as a surrogate indicator to study the P-glycoprotein modulating effect of cepharanthine hydrochloride in vivo | |
| P478 | volume | 2011 |
| Q50637693 | Determination of cepharanthine in rat plasma by LC-MS/MS and its application to a pharmacokinetic study. |
| Q34333351 | Effects of Astragalus polysaccharides on P-glycoprotein efflux pump function and protein expression in H22 hepatoma cells in vitro |
| Q36953023 | Guizhi Fuling Wan, a Traditional Chinese Herbal Formula, Sensitizes Cisplatin-Resistant Human Ovarian Cancer Cells through Inactivation of the PI3K/AKT/mTOR Pathway |
| Q36942582 | New fluphenazine analogues as inhibitors of P-glycoprotein in human lymphocyte cultures |
| Q46313262 | P-Glycoprotein Activity in Steroid-Responsive vs. Steroid-Resistant Nephrotic Syndrome |
| Q50001909 | Proteomic Differences in Feline Fibrosarcomas Grown Using Doxorubicin-Sensitive and -Resistant Cell Lines in the Chick Embryo Model |
Search more.